• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Heron Therapeutics (NQ: HRTX )

    3.500 -0.170 (-4.63%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 17, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,395,322
    Open 3.610
    Bid (Size) 3.420 (1)
    Ask (Size) 3.720 (1)
    Prev. Close 3.670
    Today's Range 3.400 - 3.730
    52wk Range 0.5000 - 3.930
    Shares Outstanding 140,759,276
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Top 3 Health Care Stocks That May Crash In May
    Via Benzinga
    HRTX Stock Earnings: Heron Therapeutics Beats EPS, Beats Revenue for Q1 2024
    HRTX stock results show that Heron Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    +85.19%
    +85.19%
    1 Month
    +8.53%
    +8.53%
    3 Month
    +26.35%
    +26.35%
    6 Month
    +59.09%
    +59.09%
    1 Year
    +150.00%
    +150.00%

    More News

    Read More
    Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Heron Therapeutics Inc. (NASDAQ: HRTX) Near the Top of Equities by Percentage Gain on 4/23
    Via Investor Brand Network
    Heron Therapeutics: Q4 Earnings Insights
    Via Benzinga
    Preview: Heron Therapeutics's Earnings
    Via Benzinga
    HealthStream Reports Upbeat Results, Joins Spotify, Ryder System And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    Why Is Postoperative Pain Focused Heron Therapeutics Stock Trading Higher On Wednesday?
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Why BlackBerry Shares Are Trading Lower By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Heron Therapeutics' Non-Opioid, Post-Operative Pain Drug Approved For Use In Additional Orthopedic, Soft Tissue Procedures - FDA Gives Nod
    Via Benzinga
    Exposures Product Safety
    Textron Posts Upbeat Earnings, Joins ASML, Progressive And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Earnings Scheduled For March 12, 2024
    Via Benzinga
    The 3 Most Undervalued Biotech Stocks to Buy in January
    Via InvestorPlace
    Hewlett Packard Enterprise, Hologic And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why LumiraDx Shares Are Trading Lower By Over 30%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    Via InvestorPlace
    Harpoon Therapeutics, Heron Therapeutics And Other Big Stocks Moving Higher In Monday's Pre-Market Session
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Penny Stock Powerhouses: 7 Picks Poised for Explosive Growth
    Via InvestorPlace
    Crude Oil Falls 2%; TJX Issues Weak Earnings Outlook
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Why Is Pain Treatment Focused Heron Therapeutics Stock Trading Higher Today?
    Via Benzinga
    Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Dow Rises Over 100 Points; Target Posts Upbeat Earnings
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.